VEGFA and neoplasm: In our series, 22 of 33 eyes had received multiple injections of VEGF inhibitors, and the tumor-related vasculature also appears to respond to anti-VEGF therapy with the regression of SRF (Figure 3), while remaining stable in size and complexity.